Breast cancer risk assessment and counseling: A clinician's guide

Breast Journal

Volumn 3, Issue 6, 1997, Pages 311-316

  Kelly, Patricia T ^a,b  

^a John Muir Medical Center   (United States)

^b NONE   (United States)

Author keywords

Assessment; Breast cancer; Counseling; Genetic testing; Heredity; Informed consent; Psychosocial; Risk

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; BREAST CANCER; CANCER RISK; CASE REPORT; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GYNECOLOGIC CANCER; HEREDITY; HORMONE SUBSTITUTION; HUMAN; INFORMED CONSENT; OVARY CANCER; PATIENT COUNSELING; PROGNOSIS; PSYCHOLOGICAL ASPECT; REVIEW; RISK ASSESSMENT;

EID: 0030657760     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4741.1997.tb00187.x     Document Type: Review

References (14)

1. Arnesson LG, Smeds S, Fagerberg G. Recurrence-free survival in patients with small breast cancer. Eur J Surg 1994; 160:271-76.
2. Tabar L, Duffy SW, Burhenne LW. New Swedish breast cancer detection results for women aged 40-49. Cancer 1993;72:1437-48.
3. Page DL, Dupont WD, Rogers LW, et al. Atypical hyperplastic lesions of the female breast. Cancer 1993;55:2698-708.
4. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131:961-72.
5. Yanick R. Cancer in older persons: magnitude of the problem - How do we apply what we know? Cancer 1994;74: 1995-2101.
6. Ozols RF, Schwartz PE, Eifel PJ. Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. In: DeVita VT, Hellman S, Rosenberg SA, eds. Principles and Practice of Oncology, 5th ed., Philadelphia: Lippincott-Raven, 1997:1502-39.
7. NIH Concensus Development Conference Statement, Ovarian cancer: screening, treatment, and follow-up. April 5-7, 1994. Gynecol Oncol 1994;55:S4.
8. Piver MS, Jishi MF, Tsukada Y, et al. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. Cancer 1993;71:2751-55.
9. Colditz GA, Stampfer MJ, Willett WC, et al. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 1991;264:2648-53.
10. Stanford JL, Weiss NS, Voigt LF, et al. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995; 274:137-42.
11. Brinton LA, Hoover R, Fraumeni JF. Menopausal oestrogens and breast cancer risk: An expanded case-control study. Br J of Cancer 1986;54:825-32.
12. Newcomb PA, Longnecker MP, Storer BE, et al. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 1995;142:788-95.
13. Dupont WD, Page DL, Rogers LW, et al. Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer 1989;63:948-57.
14. Palmer JR, Rosenberg L, Miller DR, et al. Breast cancer risk after estrogen replacement therapy: results from the Toronto breast cancer study. Am J Epidemiol 1991;134:1386-95.